News

Novo Nordisk (NYSE:NVO) announced on Tuesday that Maziar Mike Doustdar will become its new president and chief executive ...
Dr. Hodous, chief scientific officer, noted, “It has been deeply gratifying to witness the evolution of what began as a formidable scientific challenge—targeting SH2 domains as a therapeutic ...
Roland Kolbeck, Ph.D. Appointed as Chief Scientific Officer - - Joe Monahan, Ph.D. will Continue to Support Aclaris as Special Scientific Advisor to the Chief Executive Officer through March 2026 as ...
Professor Robin May will step down as the FSA’s Chief Scientific Adviser in September to become Interim Chief Scientific ...
Abdera Therapeutics Appoints Rachael Brake, Ph.D., as Chief Scientific Officer Business Wire Jul 8, 2025 ...
Experienced academic has been Food Standards Agency Chief Scientific Adviser for the last five years and will move to UKHSA ...
CAMBRIDGE, Mass.-- (BUSINESS WIRE)--Jun 9, 2025--Fable Therapeutics Appoints David J. Baker, PhD, as Chief Scientific Officer ...
Investing.com -- Novo Nordisk (NYSE: NVO) has appointed Maziar Mike Doustdar as its new president and chief executive officer, effective August 7, 2025, the company announced on Tuesday.
Aclaris Therapeutics, Inc. (NASDAQ: ACRS) announced the appointment of Roland Kolbeck, Ph.D., as its new Chief Scientific ...